Drug metabolism study for stem cell transplant patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must plan to have a stem cell transplant from a donor at the NIH Clinical Center.
- You and your donor must both agree to be in the study.
- You must be able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special type of stem cell transplant that removes certain cells to reduce complications. It may help people with blood diseases, immune problems, or other conditions that can be treated with a stem cell transplant.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
This study looks at using stem cells from a donor's bone marrow or blood to treat blood cancers like leukemia or lymphoma. It compares transplants from partially matched donors with fully matched donors to see how well they work.
This study looks at how your liver works before and after a stem cell transplant. It helps doctors understand liver problems that may happen, so they can provide better care.
This study follows people getting a stem cell transplant to watch for lung problems, like infections or other lung diseases, that can happen after the transplant. The goal is to catch these issues early.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.